ACIDE ZOLEDRONIQUE MYLAN 4 mg/5 ml, concentrate for solution for infusion bottle
Active ingredients: Anhydrous zoledronic acid, Zoledronic acid monohydrate
Commercialized according to BDPMDispensing in France: Prescription only
Concentrate for solution for infusionbottleintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ACIDE ZOLEDRONIQUE MYLAN 4 mg/5 ml, solution à diluer pour perfusion
- Pharmaceutical form
- solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre
- Marketing authorisation holder
- MYLAN PHARMACEUTICALS (IRLANDE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 21 May 2013
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68011537CIP72675601CIP133400926756017Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACIDE ZOLÉDRONIQUE ANHYDREsolution | 4 mg · 5 ml | FT |
| ACIDE ZOLÉDRONIQUE MONOHYDRATÉsolution | 4,264 mg · 5 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.